Lv0
0 积分 2024-04-18 加入
Prognostic Factors and Outcomes of Nonoperative Versus Operative Management in Adult and Pediatric Patients Following Pancreatic Trauma: A Systematic Review
45分钟前
已完结
Breaking Free from the Hazard Ratio: Embracing the Restricted Mean Survival Time in Clinical Trials
4个月前
已完结
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study
7个月前
已关闭
Non-alcoholic fatty liver disease
8个月前
已完结
PL02.12 Ivonescimab vs Placebo Plus Chemo, Phase 3 in Patients with EGFR+ NSCLC Progressed with 3rd gen EGFR-TKI Treatment: HARMONi
10个月前
已完结
MA10.03 Efficacy and Safety of Cadonilimab Plus Pulocimab in NSCLC Patients Who Progressed Following Prior Immunotherapy: A Phase 1b/2 Study
10个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
11个月前
已完结
Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial
1年前
已完结
皖公网安备34019202002308
